The role of GABA(A) receptors in the neural systems of the ventromedial-infundibular region of the hypothalamus in the control of gonadotropin release during the luteal phase in ewes.
To examine the role of GABA(A) receptor mediating systems in the control of gonadotropin-releasing hormone (GnRH) release from the ventromedial-infundibular region (VEN/NI) in ewes during luteal phase, the extracellular concentrations of GnRH, beta-endorphin, noradrenaline (NE), dopamine (DA), and their metabolites: MHPG and DOPAC were quantified by local stimulation or blockade of GABA(A) receptors with muscimol or bicuculline, respectively. Stimulation of GABA(A) receptors in the VEN/NI did not affect GnRH, beta-endorphin release or catecholaminergic system activity. Blockade of GABA(A) receptors decreased beta-endorphinergic and dopaminergic activity, and lowered the extracellular concentration of MHPG. It did not affect GnRH release or luteinizing hormone (LH) secretion. It is suggested that progesterone-induced GABAergic activity during the luteal phase may desensitize GABA(A) receptors to muscimol. Lack of changes in GnRH/LH secretion with concomitant depressed beta-endorphinergic activity corroborated the conclusion that beta-endorphin does not inhibit GnRH release from the VEN/NI during the luteal phase. The physiological significance of changes in the catecholaminergic system activity under GABA(A) receptor blockade in the control of GnRH secretion awaits to be established.
Tomaszewska-Zaremba
D
D
Polish Academy of Sciences, The Kielanowski Institute of Animal Physiology and Nutrition, 05-110 Jabłonna, Poland. d_tomaszewska@poczta.onet.pl
Mateusiak
K
K
Przekop
F
F
D015102:3,4-Dihydroxyphenylacetic Acid / Q000378:metabolism; D000818:Animals; D001640:Bicuculline / Q000494:pharmacology; D004298:Dopamine / Q000378:metabolism; D005260:Female; D018755:GABA Agonists / Q000494:pharmacology; D018756:GABA Antagonists / Q000494:pharmacology; D007987:Gonadotropin-Releasing Hormone / Q000378:metabolism; D006062:Gonadotropins / Q000378:metabolism*; D008183:Luteal Phase / Q000502:physiology; D007986:Luteinizing Hormone / Q000378:metabolism; D008734:Methoxyhydroxyphenylglycol / Q000378:metabolism; D009118:Muscimol / Q000494:pharmacology; D009638:Norepinephrine / Q000378:metabolism; D010904:Pituitary Gland, Posterior / Q000378:metabolism*; D011963:Receptors, GABA-A / Q000378:metabolism*; D012756:Sheep; D001615:beta-Endorphin / Q000378:metabolism
D018755:GABA Agonists; D018756:GABA Antagonists; D006062:Gonadotropins; D011963:Receptors, GABA-A; D015102:3,4-Dihydroxyphenylacetic Acid; D009118:Muscimol; D007987:Gonadotropin-Releasing Hormone; D008734:Methoxyhydroxyphenylglycol; D001615:beta-Endorphin; D007986:Luteinizing Hormone; D004298:Dopamine; D009638:Norepinephrine; D001640:Bicuculline